CIPLA's weekly performance was strong, with a return of 3.82%, outperforming peers SUNPHARMA and GRASIM, but slightly underperforming DIVISLAB. The stock's volatility was moderate at 16.18%, lower than DIVISLAB's but higher than SUNPHARMA's. With a Sharpe Ratio of 0.93, CIPLA's return was relatively risk-adjusted. Overall, CIPLA demonstrated a relatively stable and profitable week.

[Volatility: 16.18%]